Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium.
Brian L ErstadJeffrey F BarlettaPublished in: Critical care (London, England) (2020)
Practice guidelines provide clear evidence-based recommendations for the use of drug therapy to manage pain, agitation, and delirium associated with critical illness. Dosing recommendations however are often based on strategies used in patients with normal body habitus. Recommendations specific to critically ill patients with extreme obesity are lacking. Nonetheless, clinicians must craft dosing regimens for this population. This paper is intended to help clinicians design initial dosing regimens for medications commonly used in the management of pain, agitation, and delirium in critically ill patients with extreme obesity. A detailed literature search was conducted with an emphasis on obesity, pharmacokinetics, and dosing. Relevant manuscripts were reviewed and strategies for dosing are provided.
Keyphrases
- metabolic syndrome
- weight loss
- insulin resistance
- type diabetes
- clinical practice
- pain management
- chronic pain
- cardiac surgery
- weight gain
- high fat diet induced
- healthcare
- adipose tissue
- systematic review
- palliative care
- climate change
- primary care
- neuropathic pain
- hip fracture
- emergency department
- intensive care unit
- mesenchymal stem cells
- drug induced